Profile of elotuzumab and its potential in the treatment of multiple myeloma
{{output}}
Although the introduction of novel drugs has improved outcome significantly in multiple myeloma (MM), many patients still eventually relapse. Monoclonal antibodies (mAbs) targeting MM-related antigens can complement currently available therapies. CS1 (also kno... ...
